Back
Ultragenyx Pharmaceutical, Inc. Stock Predictions
Coinbase Lost $400M. Your Crypto Isn't Safe on Exchanges.
Stop trusting exchanges. Learn how to access Native Markets where YOU control your assets
Sell
6
RARE
Ultragenyx Pharmaceutical, Inc.
Last Price:
$23.40
Seasonality Move:
-0.15%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Ultragenyx Pharmaceutical, Inc. Stock Forecast
-
Over the next 52 weeks, Ultragenyx Pharmaceutical, Inc. has on average historically risen by 9.6% based on the past 11 years of stock performance.
-
Ultragenyx Pharmaceutical, Inc. has risen higher in 3 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 27.27%
-
Is Ultragenyx Pharmaceutical, Inc. Stock Undervalued?The current Ultragenyx Pharmaceutical, Inc. [RARE] share price is $22.75. The Score for RARE is 6, which is 88% below its historic median score of 50, and infers higher risk than normal.
-
RARE is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
Will Ultragenyx Pharmaceutical, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Ultragenyx Pharmaceutical, Inc. has on average historically risen by 9.6% based on the past 11 years of stock performance.
Ultragenyx Pharmaceutical, Inc. Stock Rating
Sell
6
Ultragenyx Pharmaceutical, Inc. (RARE)
is a Sell
Is Ultragenyx Pharmaceutical, Inc. overpriced?
-
Ultragenyx Pharmaceutical, Inc. has risen higher in 3 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 27.27%
Ultragenyx Pharmaceutical, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
ultragenyx.com
52-Week Data
52-Week High:
46.50
52-Week Low:
18.41
Prediction Charts
Market Cap:
2.3B
Price in USD:
22.75
Volume:
3M
Beta:
1.08
Technical Analysis
SMA50:
30.52
SMA100:
30.99
SMA200:
32.29
52-Wk Change:
-44.89%
Stock Predictions
-
Is Ultragenyx Pharmaceutical, Inc. stock public?Yes, Ultragenyx Pharmaceutical, Inc. is a publicly traded company.
-
What is the Ultragenyx Pharmaceutical, Inc. stock quote today?The Ultragenyx Pharmaceutical, Inc. stock price is 22.75 USD today.
-
How to buy Ultragenyx Pharmaceutical, Inc. stock online?You can buy Ultragenyx Pharmaceutical, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-31 | 22.50 | 23.00 | 23.06 | 21.90 |
| Jan-2 | 22.89 | 23.60 | 24.00 | 22.50 |
| Jan-5 | 23.42 | 23.11 | 23.75 | 22.64 |
| Jan-6 | 22.94 | 22.54 | 23.16 | 22.07 |
| Jan-7 | 22.86 | 24.20 | 24.62 | 22.73 |
| Jan-8 | 24.30 | 23.21 | 25.10 | 22.92 |
| Jan-9 | 23.46 | 22.51 | 23.90 | 22.50 |
| Jan-12 | 22.95 | 24.37 | 24.65 | 22.40 |
| Jan-13 | 24.48 | 24.11 | 24.53 | 23.47 |
| Jan-14 | 24.12 | 24.07 | 24.32 | 23.71 |
| Jan-15 | 23.87 | 23.50 | 24.12 | 23.09 |
| Jan-16 | 23.36 | 22.49 | 23.77 | 22.43 |
| Jan-20 | 22.12 | 22.63 | 22.96 | 22.00 |
| Jan-21 | 22.72 | 22.75 | 22.98 | 22.49 |
Ultragenyx Pharmaceutical, Inc. Earnings
Ultragenyx Pharmaceutical, Inc. Earnings Report: Per Share Ultragenyx Pharmaceutical, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Ultragenyx Pharmaceutical, Inc. Forecast Revenue Growth
Ultragenyx Pharmaceutical, Inc. Stock Analysis: Historical quarterly revenues per share for Ultragenyx Pharmaceutical, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.55 per share, and an increase next year of $2.47 per share.
* Ultragenyx Pharmaceutical, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.